| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Seung-Ryel Baek CEO | KRX SM Exchange | KR7003220001 ISIN |
| KR Country | 1,283 Employees | 29 Dec 2025 Last Dividend | 11 Feb 2019 Last Split | - IPO Date |
Daewon Pharmaceutical Co., Ltd. is a renowned pharmaceutical entity based in Seoul, South Korea, established in 1958. The company specializes in the manufacturing and distribution of a wide range of medicines and medical supplies, primarily catering to the South Korean market. Their product line extends across various medical domains, including circulatory, respiratory, antibiotics, chemotherapy, and psychoneurosis medications. Daewon Pharmaceutical prides itself on its expansive global footprint, exporting products to about 40 countries across Asia, Central and South America, the Middle East, CIS, and Africa. The commitment to quality and innovation has positioned Daewon Pharmaceutical as a key player in the pharmaceutical industry.
A multivitamin product designed to support overall health and wellness. Oramin-F Soft Cap caters to individuals needing to supplement their daily vitamin intake.
A Non-Steroidal Anti-Inflammatory Drug (NSAID) formulated for effective pain relief. Pelubi Tablets are typically prescribed for managing pain and inflammation associated with various conditions.
A microemulsion propofol utilized for its anti-exogenous infectious bacteria properties. Freefol-MCT Inj. is critical in medical settings for its efficacy in managing bacterial infections.
This medication is aimed at supplementing the subalimentation of cancer patients. Megex-I Susp provides essential nutrition support, addressing the unique needs of this patient population.
A therapeutic suspension formulated for the treatment of gastritis and duodenal ulcers. Trigel Susp offers relief and promotes healing in patients suffering from these gastrointestinal conditions.
A spherical carbonaceous adsorbent designed specifically for patients with chronic kidney disease (CKD). Renamezin Cap helps in managing the symptoms and progression of CKD, offering a better quality of life for sufferers.